3rd Circ. Lipitor Ruling Smooths Way In Pay-For-Delay Suits
The Third Circuit recently revived a suit accusing pharmaceutical companies of delaying generic competition for Lipitor and Effexor XR, a decision that will bolster drug buyers in pay-for-delay cases by beating...To view the full article, register now.
Already a subscriber? Click here to view full article